2025
Mortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study
Njei B, Mezzacappa C, John B, Serper M, Kaplan D, Taddei T, Mahmud N. Mortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study. Digestive Diseases And Sciences 2025, 70: 802-813. PMID: 39779587, PMCID: PMC11839701, DOI: 10.1007/s10620-024-08764-4.Peer-Reviewed Original ResearchConceptsNon-lean individualsAll-cause mortalityMajor adverse cardiovascular eventsIncreased risk of all-cause mortalityRisk of all-cause mortalityVeterans Health AdministrationRisk of hepatic decompensationPrevalence of diabetesRisk of cardiovascular mortalityHepatic decompensationHigher mortality riskCardiovascular-related mortalityCox proportional hazards modelsCohort study of patientsCardiovascular outcomesIncident major adverse cardiovascular eventsRetrospective cohort study of patientsProportional hazards modelNon-HispanicRetrospective cohort studyCompeting risk regressionHealth AdministrationMultivariate Cox proportional hazards modelLean individualsAssessed associations
2024
Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis
Nso N, Mergen D, Ikram M, Macrinici V, Hussain K, Lee K, Ugwendum D, Trimingham M, Balasubramanian S, Sam R, Njei B. Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis. Current Problems In Cardiology 2024, 49: 102569. PMID: 38599554, DOI: 10.1016/j.cpcardiol.2024.102569.Peer-Reviewed Original ResearchConceptsOdds ratioConfidence intervalsCardiovascular mortality riskPooled odds ratioAll-cause mortalityCardiometabolic profileMortality oddsMortality riskSecondary outcomesPrimary outcomeOddsMACE rateCardiovascular morbidityMeta-analysisCardiovascular outcomesLiver diseaseLean individualsSteatotic liver diseasePublication dateSample sizePatientsMACEOutcomesCohortMortalityGenetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review
Njei B, Al-Ajlouni Y, Ugwendum D, Abdu M, Forjindam A, Mohamed M. Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review. Translational Gastroenterology And Hepatology 2024, 9: 11-11. PMID: 38317742, PMCID: PMC10838615, DOI: 10.21037/tgh-23-31.Peer-Reviewed Original ResearchNewcastle Ottawa ScaleLean non-alcoholic fatty liver diseaseNon-alcoholic fatty liver diseaseSystematic reviewDeterminants of non-alcoholic fatty liver diseaseAscertainment of exposureLean individualsEpigenetic factorsModerate overall qualityFatty liver diseaseRisk of biasGene variantsPeer-reviewed studiesLiver diseaseQuality assessmentFrequent genetic risk factorGenetic risk factorsOttawa ScaleHistone variantsQualitative synthesisStudy designNAFLD riskPRISMA guidelinesEpigenetic determinantsEpigenetic contributions
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply